1. OUTCOMES OF ADULTS, ADOLESCENTS, AND CHILDREN WITH PRIMARY MEDIASTINAL B‐CELL LYMPHOMA TREATED WITH DOSE‐ADJUSTED EPOCH‐R THERAPY: a MULTICENTER RETROSPECTIVE ANALYSIS. (June 2017) Authors: Roth, L.G.; O'Donohue, T.; Chen, Z.; Bartlett, N.; Martin‐Doyle, W.; Barth, M.J.; Davies, K.; Christian, B.; Casulo, C.; Godfrey, J.; Oberley, M.J.; Alexander, S.; Weitzman, S.; Appel, B.; Svoboda, J.; Afify, Z.; Pauly, M.; Dave, H.; Gardner, R.; Stephens, D.M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TRANSCEND CLL 004: MINIMAL RESIDUAL DISEASE AFTER LISOCABTAGENE MARALEUCEL IN PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA. (12th June 2019) Authors: Siddiqi, T.; Dorritie, K.A.; Soumerai, J.D.; Stephens, D.M.; Dubovsky, J.A.; Gillenwater, H.H.; Gong, L.; Thorpe, J.; Yang, L.; Wierda, W.G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗